|
|
|
Program Co-Chairs
Ethan Rubinstein
Jerome J Schentag
Alan Tice
Program Scientific Committee
Yehuda Carmeli
Tel Aviv, Israel
William A. Craig
Madison, Wisconsin, USA
E. Patchen Dellinger
Seattle, Washington, USA
Thomas M. File Jr.
Akron, Ohio, USA
Joseph John
Charleston, S. Carolina, USA
Keith P. Klugman
Atlanta, Georgia,
USA
Hartmut Lode
Berlin, Germany
Dennis Maki
Madison, Wisconsin, USA
Michael Mulvey
Winnipeg, Manitoba, Canada
Tim Murphy
Buffalo, New York, USA
Barbara Murray
Houston, Texas, USA
Michael Niederman
New York, New York,
USA
Joseph Paladino
Buffalo, New York, USA
Richard Proctor
Madison, Wisconsin, USA
Coleman Rotstein
Toronto, Ontario,
Canada
Paul Tulkens
Brussels, Belgium
Christof von Eiff
Muenster,
Germany
Victor L. Yu
Pittsburgh, Pennsylvania, USA
|
Dear
Colleague:
It was our pleasure to host the Third International Symposium on Resistant
Gram-Positive Infections. This program was held on October 9-11, 2006 at the White Oaks Resort in Niagara-on-the-Lake, Ontario, Canada.
It is with equal
pleasure that we are announcing the
Fourth International Symposium on Resistant Gram-Positive
Organisms organized by Dr. Ethan Rubinstein, Dr. Jerome Schentag and Dr. Alan
Tice.
Antimicrobial resistance among Gram-positive pathogens has become one of the
most challenging problems in modern medicine. In the community the issues are
antibiotic resistant S. pneumoniae and Methicillin resistant S.aureus. In the
hospital the major problems are methicillin resistant staphylococci, vancomycin
resistant staphylococci, vancomycin resistant enterococci, and multiply
resistant C.difficile.
Many of these offer few effective treatments. The sense of urgency that has
been felt by physicians, investigators and the pharmaceutical industry for a few
years, is now also perceived by insurers, health delivery organizations and
policy makers on local and global levels.
This
scientific meeting will be designed to exchange new information and to update
the participants on the important developments in this rapidly changing field.
The most recent information and new study results was presented in the form of
state-of-the-art lectures, posters and accompanying symposia. Considerable time
will be dedicated to discussion of new antimicrobials with activity against
resistant Gram-positive pathogens. Accompanying symposia will present the latest data on new medications
for gram positive pathogens and mixed infection.
Attendees
will have ample opportunity to review poster material and speak to presenting
authors. Gain advice from experts in this
field and participate in the discussions at all levels, both formally and
informally.
We
hope you will join us for the Fourth International Symposium on Resistant
Gram-Positive Infections to be held in Buffalo, NY on July 9-11, 2008. 
|
|
|